Ligand Pharmaceuticals | Revenu Net

Prix De L'Action
205.32
Variation Quotidienne
2.77 1.37%
Mensuellement
3.52%
Annuel
78.14%
Q1 Prévisions
192.24




Revenu Net Changement Date
Agenus USD -25.27M 20.59M 2025-03
Amgen USD 1.33B 1.88B 2025-12
Anika Therapeutics USD -4.87M 16.99M 2025-03
Arrowhead Research USD 30.81M 54.56M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Enviri Corporation USD -127.97M 114.8M 2024-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -328.48M 41.54M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
MacroGenics USD 16.82M 53.07M 2025-09
Merck USD 2.96B 2.82B 2025-12
Pacira USD 1.64M 3.8M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Veracyte USD 41.15M 22.01M 2025-12


Ligand Pharmaceuticals Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.